Peptide Graded

Retatrutide

Is Retatrutide legal in the US?

Not yet; it is still in trials. Vials sold online are not legal products.

BSome human evidenceIn clinical trialsas of 2026-10-26

Retatrutide is an investigational drug and is not approved by the FDA for any use. Eli Lilly has said it plans to file for approval in the first quarter of 2027 after completing manufacturing data. Vials sold online as retatrutide are not a legal product; the FDA has stated that unapproved GLP-1 class drugs cannot be used in compounding. 56

No. As of October 2026 it is still in phase 3 trials. Lilly has said it plans to submit an application in early 2027. So a decision would come no sooner than late 2027. 5

Read the full Retatrutide page

More on Retatrutide

Citations

  1. StatPearls: GLP-1 receptor agonists ncbi.nlm.nih.gov
  2. Jastreboff 2023, N Engl J Med: triple-hormone-receptor agonist retatrutide for obesity, phase 2 trial pubmed.ncbi.nlm.nih.gov
  3. Sanyal 2024, Nat Med: retatrutide for metabolic dysfunction-associated steatotic liver disease, phase 2a substudy pubmed.ncbi.nlm.nih.gov
  4. Lancet 2026: TRIUMPH-2, retatrutide in adults with obesity and type 2 diabetes doi.org
  5. Eli Lilly Q2 2026 earnings release (SEC filing): retatrutide filing plans sec.gov
  6. FDA: concerns with unapproved GLP-1 drugs used for weight loss fda.gov
  7. Diabetes Obes Metab 2026: rationale and design of the TRIUMPH registrational trials pubmed.ncbi.nlm.nih.gov
  8. Eli Lilly press release, July 2026: TRIUMPH-2 and TRIUMPH-3 topline results biospace.com
  9. ClinicalTrials.gov: retatrutide trial listings clinicaltrials.gov

Reference information only, not medical advice. Drawn from the Retatrutide article, fact-checked against the cited sources. No dosing anywhere on this site.